ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 230 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q1 2015. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $443 | +98.7% | 22,754 | +28.7% | 0.00% | 0.0% |
| Q2 2023 | $223 | -3.5% | 17,677 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $231 | -26.0% | 17,677 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $312 | -99.9% | 17,677 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $269,000 | +2.7% | 17,677 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $262,000 | -34.2% | 17,677 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $398,000 | -20.4% | 17,677 | -34.8% | 0.00% | 0.0% |
| Q4 2021 | $500,000 | +28.2% | 27,107 | -7.0% | 0.00% | 0.0% |
| Q3 2021 | $390,000 | -27.8% | 29,152 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $540,000 | +23.3% | 29,152 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $438,000 | +4.0% | 29,152 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $421,000 | +66.4% | 29,152 | -6.2% | 0.00% | +100.0% |
| Q3 2020 | $253,000 | +20.5% | 31,071 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $210,000 | -4.1% | 31,071 | 0.0% | 0.00% | -50.0% |
| Q1 2020 | $219,000 | -28.2% | 31,071 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $305,000 | -10.6% | 31,071 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $341,000 | -5.5% | 31,071 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $361,000 | +13.9% | 31,071 | -6.4% | 0.00% | 0.0% |
| Q1 2019 | $317,000 | -0.9% | 33,190 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $320,000 | -32.3% | 33,190 | 0.0% | 0.00% | -33.3% |
| Q3 2018 | $473,000 | +18.8% | 33,190 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $398,000 | -2.9% | 33,190 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $410,000 | -15.1% | 33,190 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $483,000 | +2.3% | 33,190 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $472,000 | +6.1% | 33,190 | -4.8% | 0.00% | 0.0% |
| Q2 2017 | $445,000 | -13.9% | 34,867 | -14.5% | 0.00% | -25.0% |
| Q1 2017 | $517,000 | +17.0% | 40,783 | -5.9% | 0.00% | 0.0% |
| Q4 2016 | $442,000 | -23.7% | 43,318 | -1.5% | 0.00% | -20.0% |
| Q3 2016 | $579,000 | -3.3% | 43,989 | -6.7% | 0.01% | 0.0% |
| Q2 2016 | $599,000 | -8.0% | 47,130 | -4.3% | 0.01% | 0.0% |
| Q1 2016 | $651,000 | -14.1% | 49,258 | -0.0% | 0.01% | -16.7% |
| Q4 2015 | $758,000 | +24.3% | 49,267 | +0.1% | 0.01% | +20.0% |
| Q3 2015 | $610,000 | -9.5% | 49,217 | -0.1% | 0.01% | -16.7% |
| Q2 2015 | $674,000 | +14.2% | 49,278 | -0.1% | 0.01% | +20.0% |
| Q1 2015 | $590,000 | -6.1% | 49,337 | +0.3% | 0.01% | 0.0% |
| Q4 2014 | $628,000 | -5.0% | 49,193 | -0.2% | 0.01% | -16.7% |
| Q3 2014 | $661,000 | -25.6% | 49,291 | -11.0% | 0.01% | -14.3% |
| Q2 2014 | $889,000 | -15.8% | 55,385 | -5.4% | 0.01% | -22.2% |
| Q1 2014 | $1,056,000 | +16.7% | 58,543 | -0.0% | 0.01% | +12.5% |
| Q4 2013 | $905,000 | +4.1% | 58,566 | +0.2% | 0.01% | 0.0% |
| Q3 2013 | $869,000 | +15.1% | 58,464 | +0.3% | 0.01% | +14.3% |
| Q2 2013 | $755,000 | – | 58,317 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GLENHILL ADVISORS LLC | 7,659,841 | $78,207,000 | 5.54% |
| Tamarack Advisers, LP | 765,000 | $7,811,000 | 5.52% |
| Rovida Advisors Inc. | 1,501,900 | $15,334,000 | 3.41% |
| Blue Harbour Group | 9,309,695 | $95,052,000 | 3.18% |
| Casdin Capital, LLC | 280,000 | $2,859,000 | 2.36% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,988,300 | $20,301,000 | 1.97% |
| Adirondack Research & Management Inc. | 555,661 | $5,673,000 | 1.93% |
| BROADVIEW ADVISORS LLC | 1,006,550 | $10,277,000 | 1.37% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 13,268,624 | $135,473,000 | 1.25% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 4,627,481 | $47,247,000 | 0.71% |